• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Acute Leukemia Endpoints Panel

Panel Members 

·        FDA Representatives: 

o       Richard Pazdur, MD
US Food and Drug Administration

o       Patricia Keegan, MD
US Food and Drug Administration

·        ASH Liaison: 

o       Stanley L. Schrier, MD
Stanford University School of Medicine  

·        NIH Representatives: 

o       Malcolm Smith, MD, PhD
National Cancer Institute

o       Thomas A. Davis, MD
National Cancer Institute

·        Industry Representative: 

o       Martine George, MD
Johnson & Johnson Pharmaceutical

·        Pediatric Acute Lymphoid Leukemia

o       Chair: Sharon B. Murphy, MD
Children's Cancer Research Institute
The University of Texas Health Science Center at San Antonio

o       Joseph Gootenberg, MD
US Food and Drug Administration

o       William L. Carroll, MD
New York University School of Medicine

o       Malcolm Smith, MD, PhD
National Cancer Institute

·        Adult Acute Lymphoblastic Leukemia

o       Chair: Richard A. Larson, MD
The University of Chicago

o       Ann Farrell, MD 
US Food and Drug Administration

o       Susan O'Brien, MD
MD Anderson Cancer Center

o       Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center

 ·        Pediatric Acute Myeloid Leukemia

o       Chair: Franklin O. Smith, MD
University of Cincinnati College of Medicine

o       Patricia Dinndorf, MD
US Food and Drug Administration

o       Philip Breitfeld, MD
Duke University Medical Center

o       Robert J. Arceci, MD, PhD
Johns Hopkins Oncology Center 

·        Adult Acute Myeloid Leukemia

o       Chair: Martin S. Tallman, MD
Northwestern University Medical School

o       Nancy Scher, MD 
US Food and Drug Administration

o       Stephen J. Forman, MD
City of Hope National Medical Center

o       Elihu H. Estey, MD
M.D. Anderson Cancer Center

o       David Harrington, PhD
Dana Farber Cancer Institute

 

·        Acute Leukemia in the Elderly

o       Chair: Frederick R. Appelbaum, MD
Fred Hutchinson Cancer Research Center

o       Daniel Rosenblum, MD
US Food and Drug Administration

o       Richard M. Stone, MD
Dana-Farber Cancer Institute 

 

Additional Workshop Subcommittee Members Not Serving as Panelists

 

·        Pediatric Acute Lymphoid Leukemia

o       Stephen L. George, PhD
Duke University Medical Center

o       Naomi Winick, MD
University of Texas Southwestern Medical Center

o       William E Evans, PharmD
St Jude Children's Research Hospital

o       Susan L. Weiner, PhD
Children's Cause for Cancer Advocacy

·        Adult Acute Lymphoblastic Leukemia

o       Stephen L. George, PhD
Duke University Medical Center

o       James W. Vardiman, MD
University of Chicago

o       Charles Linker, MD
University of California

 ·        Pediatric Acute Myeloid Leukemia

o       Donald Small, MD, PhD
Johns Hopkins Hospital

o       Todd Alonzo, PhD
University of Southern California

o       Louis Leone, Esq.
Children's Oncology Group 

·        Adult Acute Myeloid Leukemia

o       Cheryl L. Willman, MD
University of New Mexico

o       Elisabeth Paietta, PhD
Our Lady of Mercy Medical Center

o       Ernest Beutler, MD
The Scripps Research Institute 

·        Acute Leukemia in the Elderly

o       Kenneth J. Kopecky, PhD
Southwest Oncology Group Statistical Center

o       James W. Vardiman, MD
University of Chicago

o       Stephanie Lee, MD, MPH
Dana-Farber Cancer Institute

o       Susan Stewart
BMT InfoNet

o       Wolfgang Hiddemann, PhD, MD
University Hospital Grosshadern
Ludwig-Maximilians University